Evidence map›Paper›PMID 27719692›Full record

ReviewParasitology2016

The animal trypanosomiases and their chemotherapy: a review.

Federica Giordani, Liam J Morrison, Tim G Rowan, Harry P DE Koning, Michael P Barrett

Open access · hybridAbstract readReview
In one paragraph

Review in Parasitology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 206 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
206citing papers in PubMed, 5 pooled it
21.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

206 citing papers in PubMed, 5 syntheses or guidelines pooled it, 445 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. DiverseInternational journal for parasitology. Parasites and wildlife · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Activation of Angiotensin-Converting Enzyme 2 Mitigates Gastrointestinal Acute Radiation Syndrome.International journal of radiation oncology, biology, physics · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. ML-792 impairsFrontiers in cellular and infection microbiology · 2026
    Article

146 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Federica GiordaniWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow,Glasgow G12 8TA,UK.
Liam J MorrisonRoslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh,Easter Bush,Midlothian EH25 9RG,UK.
Tim G RowanGlobal Alliance for Livestock Veterinary Medicines (GALVmed),Doherty Building,Pentlands Science Park,Bush Loan,Edinburgh EH26 0PZ,UK.
Harry P DE KoningWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow,Glasgow G12 8TA,UK.
Michael P BarrettWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow,Glasgow G12 8TA,UK.
Global Alliance for Livestock Veterinary Medicines · GBRoslin Institute · GBUniversity of Glasgow · GBWellcome Centre for Molecular Parasitology · GBWellcome Trust · GB

Funding

Biotechnology and Biological Sciences Research Council BB/N007492/1Biotechnology and Biological Sciences Research Council BB/N007999/1Wellcome Trust 104111/Z/14/Z
6 · The paper itself

Abstract

Pathogenic animal trypanosomes affecting livestock have represented a major constraint to agricultural development in Africa for centuries, and their negative economic impact is increasing in South America and Asia. Chemotherapy and chemoprophylaxis represent the main means of control. However, research into new trypanocides has remained inadequate for decades, leading to a situation where the few compounds available are losing efficacy due to the emergence of drug-resistant parasites. In this review, we provide a comprehensive overview of the current options available for the treatment and prophylaxis of the animal trypanosomiases, with a special focus on the problem of resistance. The key issues surrounding the main economically important animal trypanosome species and the diseases they cause are also presented. As new investment becomes available to develop improved tools to control the animal trypanosomiases, we stress that efforts should be directed towards a better understanding of the biology of the relevant parasite species and strains, to identify new drug targets and interrogate resistance mechanisms.

Indexed as

AfricaAnimalsAsiaCattleDrug ResistanceInsect VectorsSouth AmericaTrypanocidal AgentsTrypanosomaTrypanosomiasisTrypanosomiasis, AfricanTrypanosomiasis, BovineTsetse FliesTrypanocidal Agentsanimal trypanosomiasesdrug resistanceTrypanosoma bruceiTrypanosoma congolenseTrypanosoma vivaxveterinary trypanocide

Identifiers

PMID27719692
PMCPMC5142301
OpenAlexW2467164749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.